DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) is expected to announce its earnings results before the market opens on Monday, March 17th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
DiaMedica Therapeutics Price Performance
Shares of DMAC stock opened at $5.77 on Friday. The firm has a market capitalization of $246.73 million, a price-to-earnings ratio of -10.30 and a beta of 1.52. The business has a fifty day moving average of $5.95 and a 200 day moving average of $5.07. DiaMedica Therapeutics has a 1 year low of $2.14 and a 1 year high of $6.82.
DiaMedica Therapeutics Company Profile
Featured Stories
- Five stocks we like better than DiaMedica Therapeutics
- How to Invest in Insurance Companies: A Guide
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Learn Technical Analysis Skills to Master the Stock Market
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Stock Dividend Cuts Happen Are You Ready?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for DiaMedica Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaMedica Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.